Going Concern Warning Issued Amidst Deepening Losses and Highly Dilutive Financing

summarizeSummary

NewHydrogen, Inc. faces a going concern warning, reporting increased losses and no revenue, while relying on a highly dilutive equity financing agreement and facing over 100% potential dilution from outstanding securities.

check_boxKey Events

• Going Concern Warning Issued

  The independent auditor's report explicitly states 'substantial doubt about the Company's ability to continue as a going concern' due to recurring losses and negative cash flows.

• Deepening Financial Losses with No Revenue

  The company reported a net loss of $2.85 million for 2025, an increase from $1.81 million in 2024, and has an accumulated deficit of $180.79 million with no revenues generated to date.

• Highly Dilutive Equity Financing Agreement

  NewHydrogen entered into an equity financing agreement with GHS for up to $3 million, allowing the company to sell shares at 92.5% of the lowest traded price over a 10-day period, indicating a 'death spiral' financing structure. In 2025, $1.33 million was raised through this mechanism.

• Massive Potential Share Dilution

  The company has 565 million stock options and 228.96 million warrants outstanding, representing over 100% potential dilution if all were exercised, compared to 768.03 million common shares currently outstanding.

auto_awesomeAnalysis

NewHydrogen, Inc.'s annual report reveals a critical financial situation, with auditors expressing substantial doubt about the company's ability to continue as a going concern. The company reported a significant increase in net losses and has yet to generate any revenue. To sustain operations, NewHydrogen has entered into a highly dilutive equity financing agreement with GHS, allowing for the sale of shares at a deep discount to market prices. This financing, coupled with over 100% potential dilution from outstanding options and warrants, indicates a precarious financial runway and significant risk for existing shareholders. The company's strategic shift to focus R&D on a new green hydrogen technology with UC Santa Barbara, while potentially promising, is overshadowed by its immediate financial distress.